A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events
Crossref DOI link: https://doi.org/10.1007/s10198-016-0801-6
Published Online: 2016-05-05
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Couillerot-Peyrondet, Anne-Line
Sambuc, Cléa
Sainsaulieu, Yoël
Couchoud, Cécile
Bongiovanni-Delarozière, Isabelle
Text and Data Mining valid from 2016-05-05